jury to consider fate of ‘most hated man in America’
Shkreli, known for hiking price of life-saving Aids drug, faces securities fraud charges that could lead to 20-year sentence in a case he calls a ‘witch-hunt’
A jury will begin deliberations on Monday in the trial on securities fraud charges against the entrepreneur Martin Shkreli, who faces up to 20 years in prison.
The 34-year-old gained notoriety in 2015, when he purchased the commercial rights and then ruthlessly increased the cost of Daraprim, a life-saving Aids medication. Since then, he has maintained his reputation with a provocative presence on social media. This year he was suspended from Twitter, for harassing the journalist Lauren Duca.